Millions of people who bought DNA tests from genetic testing service 23andme have been urged to delete their personal data ...

In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

GlaxoSmithKline Pharma is shifting focus to specialty treatments and preventive healthcare, emphasizing adult vaccines and ...

GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology ...

London: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

DNA analysis company 23andme has been in trouble lately: data was breached in a 2023 hack, and this September the entire ...

EU regulators are considering withdrawing market authorizations for two hair loss and enlarged prostate treatments over ...

Naqi Logix founder Dave Segal has invented a device that lets anyone control a computer with their head—no brain implant required.

The once-hot Silicon Valley startup has seen its stock’s value decline 99% and is struggling to survive. That has put the ...

Martha Sazon, ranked No. 38 on the Fortune Most Powerful Women Asia list this year, joined Mynt as president and CEO in June ...